Osimertinib in EGFR-Mutated Advanced NSCLC

N Engl J Med. 2020 May 7;382(19):1863-1864. doi: 10.1056/NEJMc2001514.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acrylamides
  • Aniline Compounds
  • Carcinoma, Non-Small-Cell Lung*
  • ErbB Receptors
  • Humans
  • Lung Neoplasms*

Substances

  • Acrylamides
  • Aniline Compounds
  • osimertinib
  • EGFR protein, human
  • ErbB Receptors